Screening attendance, age group and diabetic retinopathy level at first screen

Diabetic Medicine

Volumn 33, Issue 7, 2016, Pages 904-911

  Scanlon, P H ^a   Stratton, I M ^a   Leese, G P ^b   Bachmann, M O ^c   Land, M ^d   Jones, C ^e   Ferguson, B ^f  

^a Gloucestershire Retinal Research Group   (United Kingdom)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

^c UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^d Landmark Health Consulting   (United Kingdom)

^e NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

^f PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CHILD; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETIC RETINOPATHY; DISEASE SEVERITY; EYE EXAMINATION; FEMALE; GROUPS BY AGE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT ATTENDANCE; REGISTRATION; SCREENING;

EID: 84975131405     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/dme.12957     Document Type: Article

References (18)

1. Number of People Diagnosed with Diabetes Reaches Three Million. 2013. Available at https://www.diabetes.org.uk/About_us/News_Landing_Page/Number-of-people-diagnosed-with-diabetes-reaches-three-million/ Last accessed 23 May 2015.
2. Stratton IM, Adler AI, Aldington S, Histed M, Taylor DJ, Scanlon P. A simple algorithm to estimate the time to development of sight-threatening diabetic retinopathy. The Lancet 2012; 380: S69.
3. Leese GP, Stratton IM, Land M, Bachmann MO, Jones C, Scanlon P et al. Progression of diabetes retinal status within community screening programs and potential implications for screening intervals. Diabetes Care 2015; 38: 488–94.
4. Scanlon PH, Aldington SJ, Stratton IM. Delay in diabetic retinopathy screening increases the rate of detection of referable diabetic retinopathy. Diabet Med 2014; 31: 439–442.
5. National Institute for Health and Care Excellence. Type 1 Diabetes: Diagnosis and Management of Type 1 Diabetes in Children, Young People and Adults. Clinical guideline 15. Available at http://www.nice.org.uk/guidance/cg15/chapter/1-recommendations#/identification-and-management-of-complications Last accessed 23 May 2015.
6. National Institute for Health and Care Excellence. Type 2 Diabetes: The Management of Type 2 Diabetes. Clinical guideline 87. Available at http://www.nice.org.uk/guidance/cg87/chapter/1-recommendations#/eye-damage Last accessed 23 May 2015.
7. SIGN 116: Management of Diabetes. 2010. Available at http://www.sign.ac.uk/guidelines/fulltext/116/ Last accessed 23 May 2015.
8. Harding S, Greenwood R, Aldington S, Gibson J, Owens D, Taylor R et al. Grading and disease management in national screening for diabetic retinopathy in England and Wales. Diabet Med 2003; 20: 965–971.
9. Early Treatment Diabetic Retinopathy Study Research Group. Grading diabetic retinopathy from stereoscopic color fundus photographs – an extension of the modified Airlie House classification. ETDRS report number 10. Ophthalmology 1991; 98: 786–806.
10. Early Treatment Diabetic Retinopathy Study Research Group. Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS report number 12. Ophthalmology 1991; 98: 823–833.
11. Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. IX. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 1989; 107: 237–243.
12. Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. X. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is 30 years or more. Arch Ophthalmol 1989; 107: 244–249.
13. Leese GP, Boyle P, Feng Z, Emslie-Smith A, Ellis JD. Screening uptake in a well-established diabetic retinopathy screening program: the role of geographical access and deprivation. Diabetes Care 2008; 31: 2131–2135.
14. Millett C, Dodhia H. Diabetes retinopathy screening: audit of equity in participation and selected outcomes in South East London. J Med Screen 2006; 13: 152–155.
15. Scanlon PH, Carter SC, Foy C, Husband RF, Abbas J, Bachmann MO. Diabetic retinopathy and socioeconomic deprivation in Gloucestershire. J Med Screen 2008; 15: 118–121.
16. Lindenmeyer A, Sturt JA, Hipwell A, Stratton IM, Al-Athamneh N, Gadsby R et al. Influence of primary care practices on patients' uptake of diabetic retinopathy screening: a qualitative case study. Br J Gen Pract 2014; 64: e484–e492.
17. Sachdeva A, Stratton IM, Unwin J, Moreton R, Scanlon PH. Diabetic retinopathy screening: study to determine risk factors for non-attendance. Diabetes & Primary Care 2012; 14: 308–316.
18. Zoega GM, Gunnarsdottir T, Bjornsdottir S, Hreietharsson AB, Viggosson G, Stefansson E. Screening compliance and visual outcome in diabetes. Acta Ophthalmol Scand 2005; 83: 687–690.